TY - JOUR T1 - Longitudinal caries prevalence in a comprehensive, multi-component, school-based prevention program JF - medRxiv DO - 10.1101/2020.10.22.20217760 SP - 2020.10.22.20217760 AU - Jacqueline R. Starr AU - Ryan R. Ruff AU - Joseph Palmisano AU - J. Max Goodson AU - Omair M. Bukhari AU - Richard Niederman Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/10/26/2020.10.22.20217760.abstract N2 - Background Globally, children’s caries prevalence exceeds 30% and has not markedly changed in 30 years. School-based caries prevention programs may be an effective method to reduce caries prevalence, obviate traditional barriers to care, and use aerosol-free interventions. The objective of this study was to explore the clinical effectiveness of a comprehensive school-based, aerosol-free, caries prevention program.Methods We conducted a 6-year prospective open cohort study in 33 U.S. public elementary schools, providing care to 6,927 children in communities with and without water fluoridation. Following a dental examination, dental hygienists provided twice-yearly prophylaxis, glass ionomer sealants, glass ionomer interim therapeutic restorations, fluoride varnish, toothbrushes, fluoride toothpaste, oral hygiene instruction, and referral to community dentists as needed. We used generalized estimating equations to estimate the change in the prevalence of untreated caries over time.Results The prevalence of untreated caries decreased by greater than 50%: from 39% to 18% in phase 1, and from 28% to 10% in phase 2. The per-visit adjusted odds ratio of untreated decay was 0.79 (95% CI: 0.73, 0.85).Conclusions and Practical Implications We show that a school-based comprehensive caries prevention program was associated with substantial reductions in children’s caries, supporting the concept of expanding traditional practices to include office- and community-based aerosol-free care.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe study was funded in part by an award from the National Institutes of Health and the National Institute on Minority Health and Health Disparities (#U24MDD006964)Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The Forsyth Institute, Boston, MA Investigational Review Board approved this study. Reporting follows STROBE guidelinesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data requests must be made in writing to the corresponding author. ER -